Skip to main content
No. of Recommendations: 2
Link to Cramer interviewing Kevin Conroy (EXAS CEO) on Mad Money yesterday after the earnings release and acquisition announcement.

They discuss the merger, the merits of Genomic Health, and the earnings release. But my favorite Cramer assessment (which I agree with) is around the 7:00 minute mark when Cramer states (paraphrasing) that he feels without the merger announcement, EXAS stock would have been up $30 after the blow out quarter, and that the quarter was the biggest blow out of the year!

I feel it will still add that $30 (or whatever amount this quarter ends up adding to the stock price), but slowly, rather than in one day. With the sizable increase in estimated revenue, analyst estimates will need to be increased across the board which will pull the stock up as those come in.

Just my feelings, do your own DD.
Print the post  


What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.